The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation

Anandamide was the first brain metabolite shown to act as a ligand of “central” CB1 cannabinoid receptors. Here we report that the endogenous cannabinoid potently and selectively inhibits the proliferation of human breast cancer cells in vitro. Anandamide dose-dependently inhibited the proliferation...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Proc Natl Acad Sci U S A
Principais autores:	De Petrocellis, Luciano, Melck, Dominique, Palmisano, Antonella, Bisogno, Tiziana, Laezza, Chiara, Bifulco, Maurizio, Di Marzo, Vincenzo
Formato:	Artigo
Idioma:	Inglês
Publicado em:	National Academy of Sciences 1998
Assuntos:	Biological Sciences
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC20983/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9653194/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.95.14.8375
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!